We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $12.8B
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
-1.98%
1 Year Est. Return
+48.82%
3 Year Est. Return
+110.09%
5 Year Est. Return
+134.03%
10 Year Est. Return
+612.52%
AUM
$9.06B
AUM Growth
-$208M
Cap. Flow
+$200M
Cap. Flow %
2.21%
Top 10 Hldgs %
12.14%
Holding
854
New
14
Increased
123
Reduced
229
Closed
455

Sector Composition

Rank Sector Weight
1 Industrials 16.92%
2 Healthcare 16.87%
3 Technology 15.88%
4 Financials 12.87%
5 Consumer Discretionary 11.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVR icon
276
Evercore
EVR
$11.5B
$3.08M 0.03%
37,469
+18,964
+102% +$1.79M
OEC icon
277
Orion
OEC
$364M
$3.08M 0.03%
230,571
-24,885
-10% -$404K
BLFY
278
DELISTED
Blue Foundry Bancorp
BLFY
$3.07M 0.03%
275,165
-14,350
-5% -$168K
PKE icon
279
Park Aerospace
PKE
$828M
$3.01M 0.03%
272,538
-14,000
-5% -$165K
XHR
280
Xenia Hotels & Resorts
XHR
$1.73B
$2.89M 0.03%
209,636
-22,515
-10% -$359K
FWRG icon
281
First Watch Restaurant Group
FWRG
$781M
$2.88M 0.03%
199,205
+28,498
+17% +$463K
CSL icon
282
Carlisle Companies
CSL
$15.2B
$2.83M 0.03%
10,094
-8,280
-45% -$2.37M
SILK
283
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$2.83M 0.03%
62,880
-3,050
-5% -$131K
DCI icon
284
Donaldson
DCI
$11.2B
$2.78M 0.03%
56,710
-2,850
-5% -$149K
VSEC icon
285
VSE Corp
VSEC
$6.81B
$2.77M 0.03%
78,335
-4,550
-5% -$177K
TNET icon
286
TriNet
TNET
$3.07B
$2.74M 0.03%
38,455
-1,100
-3% -$89.5K
HI
287
DELISTED
Hillenbrand
HI
$2.74M 0.03%
74,559
-7,870
-10% -$331K
SSNC icon
288
SS&C Technologies
SSNC
$18.8B
$2.7M 0.03%
56,571
+28,992
+105% +$1.67M
EQC
289
DELISTED
Equity Commonwealth
EQC
$2.63M 0.03%
108,032
-5,500
-5% -$148K
LGND icon
290
Ligand Pharmaceuticals
LGND
$5.85B
$2.62M 0.03%
48,738
-5,219
-10% -$307K
CSII
291
DELISTED
Cardiovascular Systems, Inc.
CSII
$2.61M 0.03%
188,200
-2,517
-1% -$37.4K
NSIT icon
292
Insight Enterprises
NSIT
$4.54B
$2.57M 0.03%
31,175
-1,200
-4% -$107K
WSBC icon
293
WesBanco
WSBC
$4.07B
$2.54M 0.03%
76,053
-8,170
-10% -$277K
CNXC icon
294
Concentrix
CNXC
$1.5B
$2.53M 0.03%
+22,645
New +$2.9M
HRI icon
295
Herc Holdings
HRI
$5.63B
$2.45M 0.03%
23,585
-491
-2% -$54.6K
SPNE
296
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$2.43M 0.03%
428,484
+73,126
+21% +$465K
IMAX icon
297
IMAX
IMAX
$2.81B
$2.4M 0.03%
169,795
-18,235
-10% -$293K
LCII icon
298
LCI Industries
LCII
$2.6B
$2.34M 0.03%
23,019
-2,434
-10% -$296K
WOR icon
299
Worthington Enterprises
WOR
$2.78B
$2.29M 0.03%
97,615
-10,527
-10% -$322K
SEI
300
Solaris Energy Infrastructure
SEI
$4.07B
$2.23M 0.02%
238,745
-25,415
-10% -$262K

Similar funds

GW&K Investment Management's Q3 2022 Portfolio in Review

As of Q3 2022, GW&K Investment Management held 854 positions worth $9.06B, down 2.2% from $9.27B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GW&K Investment Management's Q3 2022 filing shows 14 new, 123 increased, 229 reduced and 455 closed positions. Its largest new stake was Lincoln Electric: 236,966 shares worth $29.8M. The largest sale was ChemoCentryx, Inc., an estimated $35.3M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

  • GW&K Investment Management's largest Q3 2022 buy was Lincoln Electric: 236,966 shares worth $29.8M.
  • GW&K Investment Management added most to Intra-Cellular Therapies Inc. in Q3 2022, an estimated $46.1M increase.
  • GW&K Investment Management's biggest Q3 2022 reduction was ChemoCentryx, Inc., cutting an estimated $35.3M.
  • GW&K Investment Management fully exited PS Business Parks, Inc. in Q3 2022, selling an estimated $30.9M.
  • GW&K Investment Management's ten largest holdings make up 12% of its $9.06B portfolio in Q3 2022.
  • GW&K Investment Management opened 14 new positions and closed 455 in Q3 2022.
  • GW&K Investment Management's portfolio value fell 2.2% quarter-over-quarter to $9.06B.

Based on GW&K Investment Management's 13F filing for Q3 2022, filed 9 Nov 2022.